Resources

Outpost Bio has raised $3.5 million in pre-seed funding to build frontier AI models that make human microbiology computable, enabling more precise prediction and optimization of intervention outcomes.

This story is to announce the exciting news that Joanne Anderson has joined Symbiosis as Chief Commercial Officer.

Firefinch Software has joined the Association of British HealthTech Industries (ABHI), aligning its specialist software capabilities with the UK’s leading healthtech network to better support health tech and medical device developers. This milestone coincides with Firefinch’s UK and Europe training roadshow, offering hands on support to teams building compliant software for medical devices.

22,000 sq ft of space in Wilton Centre’s Technical Development Area (TDA) has been leased to growing companies breathing new life into used metals and accelerating Teesside’s net zero ambitions.

It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.

In this guest blog, Hareklea Markides, Innovation Lead - Medicines Manufacturing at Innovate UK, reflects on the UK BioIndustry Association's (BIA) annual #bioProcessUK conference.

FUJIFILM Biotechnologies celebrated the grand opening of its expanded site in Teesside, UK, today.

In this blog, Abby Clark, Manufacturing Programme Manager at BIA, highlights some of the key achievements of BIA and ABPI’s Medicines Manufacturing Industry Partnership (MMIP).

A bumper update today as we highlight the critical importance of building UK capability and innovation leadership as geopolitics continues to provide uncertainty.

Fleet Bioprocessing Ltd has announced the launch of a new contract development service for Lateral Flow Devices (LFDs), expanding its capabilities in response to strong growth in point-of-care and decentralised diagnostics.

As 2026 shapes up to an unpredictable year, our policy experts have provided more grounding for what the life sciences sector should expect over the next 12 months. This is the second and final part of our 2026 outlook series. 

Pioneer Group, a specialist in life science infrastructure and venture building, and global biopharmaceutical company AbbVie, have crowned Alceus Bio the winner of their 2025 Golden Ticket programme.

Precision treatments tackling the hardest-to-treat cancers set to be produced from hundreds of tonnes of reprocessed uranium from nuclear reactors

Particology has been selected for an £8.2 million Government-funded research consortium to make the manufacture of medicines more efficient and sustainable. 

BIA thought leadership takes centre stage with two key reports published: last week saw the release of 'From innovation to impact: unlocking patient access to innovative rare disease medicines', and today 'UK cell and gene therapy: driving efficiencies and innovation' celebrates real-world UK success.

Our latest report demonstrates the real-world success and scalable manufacturing available in the UK’s globally competitive ecosystem.

In this blog, Ethan Almond, Content & Communications Executive at BIA, explores the influence of the BIA’s bioProcessUK conference. The 22nd edition highlighted the UK’s leadership in bioprocessing.

The BioIndustry Association (BIA) released From Innovation to Impact: Unlocking Patient Access to Innovative Rare Disease Medicines, calling for new pathway to give UK patients access to innovative rare disease medicines.

IRCA Group, a global leader in high-quality food ingredients, has signed a lease at Pioneer Group’s new food and beverage incubator, Gastronomica at Colworth Science Park in Bedfordshire.